An outbreak of hepatitis B virus infection among methamphetamine injectors: The role of sharing injection drug equipment

Addiction

Volumn 101, Issue 5, 2006, Pages 726-730

  Vogt, Tara M ^a   Perz, Joseph F ^a   Van Houten Jr , Clayton K ^b   Harrington, Robert ^c   Hansuld, Tia ^c   Bialek, Stephanie R ^a   Johnston, Robert ^b   Bratlie, Rachel ^a   Williams, Ian T ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Preventive Health and Safety Division   (United States)

^c Casper Natrona County Health Department   (United States)

Author keywords

Disease outbreaks; Hepatitis B; Intravenous; Methamphetamine; Substance abuse; Vaccination

Indexed keywords

HEPATITIS B VACCINE; METHAMPHETAMINE;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; COTTON; DISEASE COURSE; FEMALE; HEALTH BEHAVIOR; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; RURAL AREA; SEXUAL BEHAVIOR; UNITED STATES; VACCINATION; VIRUS INFECTION;

ADULT; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE OUTBREAKS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; NEEDLE SHARING; RISK FACTORS; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; WYOMING;

EID: 33645993907     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2006.01407.x     Document Type: Article

References (15)

1. Roberts D. L. Ball J. 2004 The DAWN Report Amphetamine and Methamphetamine Emergency Department Visits, 1995-2002. Rockville, MD Office of Applied Studies, Substance Abuse and Mental Health Services Administration.
2. Singh D. 2001 Wyoming's methamphetamine initiative: the power of informed process. Bulletins from the Field: Practitioner Perspectives May 1 15.
3. Gibson D. R. Leamon M. H. Flynn N. 2002 Epidemiology and public health consequences of methamphetamine use in California's Central Valley. Journal of Psychoactive Drugs 34 313 319.
4. Centers for Disease Control and Prevention 2005 ) Hepatitis Surveillance Report no. 60. Atlanta, GA US Department of Health and Human Services, Centers for Disease Control and Prevention.
5. Bialek S. R. Bower W. A. Mottram K. Purchase D. Nakano T. Nainan O. et al. 2005 Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users. Journal of Urban Health 82 468 478.
6. Hagan H. Thiede H. Weiss N. S. Hopkins S. G. Duchin J. S. Alexander E. R. 2001 Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health 91 42 46.
7. Thorpe L. E. Ouellet L. J. Hershow R. Bailey S. L. Williams I. T. Williamson J. et al. 2002 Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology 155 645 653.
8. Villano S. A. Vlahov D. Nelson K. E. Lyles C. M. Cohn S. Thomas D. L. 1997 Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. Journal of Clinical Microbiology 35 3274 3277.
9. Recommendation of the Immunization Practices Advisory Committee (ACIP 1982 Inactivated hepatitis B virus vaccine. Morbidity and Mortality Weekly Report 31 317 318.
10. Rich J. D. Ching C. G. Lally M. A. Gaitanis M. M. Schwartzapfel B. Charuvastra A. et al. 2003 A review of the case for hepatitis B vaccination of high-risk adults. American Journal of Medicine 114 316 318.
11. Myatt M. 2001 Epigram - Simple Software for Simple Diagrams. London, UK Brixton Health and ICEH.
12. Koester S. K. Glantz J. Barón A. 2005 Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. Aids and Behavior 9 27 39.
13. Favero M. S. Bolyard E. A. 1995 Microbiologic considerations. Disinfection and sterilization strategies and the potential for airborne transmission of bloodborne pathogens. Surgical Clinics of North America 75 1071 1089.
14. Substance Abuse and Mental Health Services Administration 2004 Results from the 2003 National Survey on Drug Use and Health: National Findings. Publication no. SMA 04-3964, series H-25. Rockville, MD Office of Applied Statistics.
15. National Drug Intelligence Center 2004 National Drug Threat Assessment 2004. Product no 2004-Q0317-002. Johnstown, PA US Department of Justice.